Cadila Pharmaceuticals Limited — Erythromycin Exporter Profile
Indian Pharmaceutical Exporter · #6 for Erythromycin · $1.4M export value · DGFT Verified
Cadila Pharmaceuticals Limited is the #6 Indian exporter of Erythromycin with $1.4M in export value and 69 verified shipments. Cadila Pharmaceuticals Limited holds a 1.8% market share in Erythromycin exports across 5 countries. The company exports 15 pharmaceutical products worth $20.2M across 11 therapeutic categories.
Cadila Pharmaceuticals Limited — Erythromycin Export Profile: Buyers & Destinations
Where Does Cadila Pharmaceuticals Limited Export Erythromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.2M | 58 | 91.5% |
| FRANCE | $47.6K | 5 | 3.5% |
| ZIMBABWE | $44.2K | 4 | 3.3% |
| BELGIUM | $11.9K | 1 | 0.9% |
| JAMAICA | $10.5K | 2 |